4594
TSE Growth
BrightPath Biotherapeutics Co., Ltd.
Result
44
JPY
-1
(-2.22%)
Jun 12, 3:30 pm JST
0.27
USD
Jun 12, 2:30 am EDT
PER
ー
PBR
2.60
Yield
ー%
Margin Trading Ratio
13.42
PTS
outside of trading hours
44.1
Jun 12, 11:58 pm JST
BrightPath Biotherapeutics, Apr-Jun (1Q) Net Income Loss Narrows
Fri Aug 8, 2025 3:30 pm JST
Earnings
4594 BrightPath Biotherapeutics Co., Ltd. 【J-GAAP】
Earnings ReportBrightPath Biotherapeutics Co., Ltd. <4594> [TSE Growth] announced its financial results after the market closed on August 8th (15:30). The net loss (non-consolidated) for the first quarter of the fiscal year ending March 2026 (April to June) was a reduced loss of 241 million yen (compared to a loss of 330 million yen in the same period last year).
Kabutan News
Actual Performance and Financial Trends
Accumulated Results 1st Quarter
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Progress Rate vs. First Half |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
0M | -293M | -293M | -295M | -4.7 | ー | Aug 10, 2023 | J-GAAP |
|
|
0M | -326M | -329M | -330M | -4.7 | ー | Aug 9, 2024 | J-GAAP |
|
|
0M | -245M | -240M | -241M | -2.6 | ー | Aug 8, 2025 | J-GAAP |
| YoY | － | +24.8% | +27.1% | +27.0% | +44.4% |
Current Period Guidance
First Half Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
0M | -542M | -537M | -538M | -7.1 | 0 | Nov 8, 2024 | J-GAAP |
|
Guidance
Apr - Sep, 2025
|
ー | ー | ー | ー | － | 0 | May 9, 2025 | J-GAAP |
| YoY | － | － | － | － | － |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
0M | -1,155M | -1,158M | -1,168M | -18.2 | 0 | May 10, 2024 | J-GAAP |
|
|
1M | -1,160M | -1,147M | -1,151M | -14.1 | 0 | May 9, 2025 | J-GAAP |
|
Guidance
Mar, 2026
|
0M | -1,182M | -1,164M | -1,166M | -8.6 | 0 | May 9, 2025 | J-GAAP |
| YoY | － | -1.9% | -1.5% | -1.3% | +38.9% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
0M | -326M | -329M | -330M | -4.7 | -Inf | Aug 9, 2024 | J-GAAP |
|
|
0M | -216M | -208M | -208M | -2.8 | -Inf | Nov 8, 2024 | J-GAAP |
|
|
0M | -273M | -275M | -277M | -3.5 | -Inf | Feb 14, 2025 | J-GAAP |
|
|
1M | -345M | -335M | -336M | -4.1 | -34,500.0 | May 9, 2025 | J-GAAP |
|
|
0M | -245M | -240M | -241M | -2.6 | -Inf | Aug 8, 2025 | J-GAAP |
| YoY | － | +24.8% | +27.1% | +27.0% | +44.4% |